Copy
New and Notable Evidence 2023
View this email in your browser
Trusted evidence. Informed decisions. Better health.

New and Notable Evidence | December 2023*

*This is the first of three emails covering September - November 2023
Listing of articles does not imply recommendation.
Please forward this email to anyone you think would be interested in it!

Content:

Abortion 
Guidelines
Practice and development of male contraception: European Academy of Andrology and American Society of Andrology guidelines.
Wang C, Meriggiola MC, Amory JK, Barratt CLR, Behre HM, Bremner WJ, Ferlin A, Honig S, Kopa Z, Lo K, Nieschlag E, Page ST, Sandlow J, Sitruk-Ware R, Swerdloff RS, Wu FCW, Goulis DG.
Andrology. 2023 Sep 20.
DOI: 10.1111/andr.13525. PMID: 37727884

Society of Family Planning Clinical Recommendation: Management of hemorrhage at the time of abortion.
Kerns JL, Brown K, Nippita S, Steinauer J.
Contraception. 2023 Sep 20:110292.
DOI: 10.1016/j.contraception.2023.110292. PMID: 37739302

Society of Family Planning Clinical Recommendation: Medication abortion between 14 0/7 and 27 6/7 weeks of gestation: Jointly developed with the Society for Maternal-Fetal Medicine.
Zwerling B, Edelman A, Jackson A, Burke A, Prabhu M.
Am J Obstet Gynecol. 2023 Oct 9:S0002-9378(23)00726-3.
DOI: 10.1016/j.ajog.2023.09.097. PMID: 37821258 

Trials / Interrupted Time Series
Changes in Induced Medical and Procedural Abortion Rates in a Commercially Insured Population, 2018 to 2022 : An Interrupted Time-Series Analysis.
Hwang CS, Kesselheim AS, Sarpatwari A, Huybrechts KF, Brill G, Rome BN.
Ann Intern Med. 2023 Nov;176(11):1508-1515.
DOI: 10.7326/M23-1609. PMID: 37871317

Comparing letrozole and mifepristone pre-treatment in medical management of first trimester missed miscarriage: a prospective open-label non-inferiority randomised controlled trial.
Du L, Li HWR, Gemzell-Danielsson K, Zhang Z, Du Y, Zhang W, Xu B, Wang X, Wang Y, Wan W, Chang Y, Diao W, Wang Y, Zhang L, Ho PC.
BJOG. 2023 Sep 5.
DOI: 10.1111/1471-0528.17646. PMID: 37667661

Effects of aromatherapy on patient satisfaction with procedural abortion at less than 10 weeks' gestation: A randomized controlled trial.
Free LL, Sheeder J, Cohen RH.
Contraception. 2023 Oct 17:110311.
DOI: 10.1016/j.contraception.2023.110311. PMID: 37858617

Impact of approval of home use of misoprostol in England on access to medical abortion: An interrupted time series analysis.
Lewandowska M, Carter DJ, Gasparrini A, Lohr PA, Wellings K.Int
J Gynaecol Obstet. 2023 Aug 24.
DOI: 10.1002/ijgo.15044. PMID: 37621171

Intravenous Ketamine for Pain Control in First-Trimester Surgical Abortion: Interim Analysis of a Randomized Controlled Trial.
Nelles-McGee T, Waddington A, Pudwell J, Zouros I, Gibson SME.
J Obstet Gynaecol Can. 2023 Oct 10:102235.
DOI: 10.1016/j.jogc.2023.102235. PMID: 37820929

Reviews
Adjuvants to prevent reformation of adhesions following adhesiolysis for Asherman syndrome: a systematic review and meta-analysis.
Guo J, Shi X, Yu F, Cao JH, Xia E, Zhai J, Mol BWJ, Li TC.
Hum Fertil (Camb). 2023 Oct 1:1-18.
DOI: 10.1080/14647273.2023.2254492. PMID: 37778374 

High-frequency, high-intensity transcutaneous electrical nerve stimulation compared with opioids for pain relief after gynecological surgery: a systematic review and meta-analysis. [FREE FULL TEXT]
Piasecki A, Ögren C, Thörn SE, Olausson A, Svensson CJ, Platon B, Wolf A, Andréll P.
Scand J Pain. 2023 Oct 12.
DOI: 10.1515/sjpain-2023-0068. PMID: 37819201

Prior Cesarean Birth and Risk of Uterine Rupture in Second-Trimester Medication Abortions Using Mifepristone and Misoprostol: A Systematic Review and Meta-analysis.
Henkel A, Miller HE, Zhang J, Lyell DJ, Shaw KA.
Obstet Gynecol. 2023 Dec 1;142(6):1357-1364.
DOI: 10.1097/AOG.0000000000005259. PMID: 37884011

Reversal of medication abortion with progesterone: a systematic review.
Stifani BM, Lavelanet AF.
BMJ Sex Reprod Health. 2023 Oct 20:bmjsrh-2023-201875.
DOI: 10.1136/bmjsrh-2023-201875. PMID: 37863512

Roots, Leaves, and Flowers: A Narrative Review of Herbs and Botanicals Used for Self-Managed Abortion in Asia and the Pacific.
Chen TX, Hamachi A, Soon R, Natavio M.J
Midwifery Womens Health. 2023 Sep 5.
DOI: 10.1111/jmwh.13561. PMID: 37668006 

Contraception 
Trials
Contraception use and satisfaction among mothers with low income: Evidence from the Baby's First Years study.
Costanzo MA, Magnuson KA, Gennetian LA, Halpern-Meekin S, Noble KG, Yoshikawa H.
Contraception. 2023 Oct 6:110297.
DOI: 10.1016/j.contraception.2023.110297. PMID: 37806470

The efficacy, safety, and tolerability of an estrogen-free oral contraceptive drospirenone 4 mg (24/4-day regimen) in obese users.
Creinin MD, Angulo A, Colli E, Archer DF.
Contraception. 2023 Dec;128:110136.
DOI: 10.1016/j.contraception.2023.110136. PMID: 37544572

Effect of prenatal counseling on postpartum follow-up and contraceptive use in women with gestational diabetes mellitus: a randomized controlled trial. [FREE FULL TEXT]
Phaloprakarn C, Suthasmalee S.
Am J Obstet Gynecol MFM. 2023 Oct;5(10):101107.
DOI: 10.1016/j.ajogmf.2023.101107. PMID: 37527735 

Factors affecting female sexual well-being: a 5-year follow-up of a randomised clinical trial on post-abortion contraception.
Bosas J, Toffol E, Pohjoranta E, Mentula MJ, Hurskainen R, Suhonen S, Heikinheimo O.
BMJ Sex Reprod Health. 2023 Oct 19:bmjsrh-2023-201879.
DOI: 10.1136/bmjsrh-2023-201879. PMID: 37857463

Oral Contraceptive Pills Increase Circulating 25-Hydroxy-Vitamin D Concentrations in Women Who Are Lactating.
Huff LL, Schulz EV, Richardson CD, Ebeling MD, Shary JR, Hollis BW, Wagner CL.
AM J Perinatol. 2023 Sep 19.
DOI: 10.1055/s-0043-1775561. PMID: 37726015

Systems analysis reveals differential expression of endocervical genes in African women randomized to DMPA-IM, LNG implant or cu-IUD. [FREE FULL TEXT]
Gupta PM, Balle C, Tharp GK, Nelson SA, Gasper MA, Brown B, Alisoltani A, Onono M, Palanee-Phillips T, Nair G, Ayele H, Noel-Romas L, Passmore JS, Burgener AD, Heffron R, Jaspan HB, Bosinger SE.
Clin Immunol. 2023 Oct;255:109750.
DOI: 10.1016/j.clim.2023.109750. PMID: 37660744 

Reviews
Cost Savings and Effectiveness of Long-Acting Reversible Contraception (LARC) on the Prevention of Pregnancy in Adolescents: A Systematic Review.
Marmett B, Guaranha DDFK, Carvalho AF, Reis JM, Souza CLE, Dalcin TC, Amantéa SL.
J Pediatr Adolesc Gynecol. 2023 Oct 4:S1083-3188(23)00407-2.
DOI: 10.1016/j.jpag.2023.09.008. PMID: 37802383 

The Effect of Hormonal Contraceptive Use on Skeletal Muscle Hypertrophy, Power and Strength Adaptations to Resistance Exercise Training: A Systematic Review and Multilevel Meta-analysis.
Nolan D, McNulty KL, Manninen M, Egan B.
Sports Med. 2023 Sep 27.
DOI: 10.1007/s40279-023-01911-3. PMID: 37755666

Googling long-acting reversible contraception: A scoping review examining the information available online about intrauterine devices and contraceptive implants.
Caddy C, Coombe J.
Health Promot J Austr. 2023 Sep 12.
DOI: 10.1002/hpja.806. PMID: 37700511 

An Integrative Review of Extended Use of Intrauterine Devices.
Harrison CV, Igwe-Kalu C, Eide L.
Nurs Womens Health. 2023 Oct 17:S1751-4851(23)00204-0.
DOI: 10.1016/j.nwh.2023.06.005. PMID: 37863119 

Vasovasostomy: A systematic review and meta-analysis comparing macroscopic, microsurgical, and robot-assisted microsurgical techniques.
Seth I, Gibson D, Bulloch G, Joseph K, Cevik J, Qin KR, Shahbaz S, Rozen WM.
Andrology. 2023 Oct 7.
DOI: 10.1111/andr.13543. PMID: 37804499

Family Planning 
Trials
Providing family planning counseling services for women with chronic medical conditions in an inpatient setting: A randomized feasibility trial.
Spielvogel R, Stephens RB, Clark R, Guillen M, Hankins A, Parise C.
Contraception. 2023 Dec;128:110133.
DOI: 10.1016/j.contraception.2023.110133. PMID: 37549724 
Listing of articles does not imply recommendation.
Please forward this email to anyone you think would be interested in it!

New & Notable Evidence is a free monthly email service of the
Cochrane Fertility Regulation Review Group
 
Keep up to date and subscribe here!
Website
Website
Twitter
Twitter
Email
Email
Copyright © 2023 Cochrane Fertility Regulation Group, All rights reserved.


unsubscribe from this list    update subscription preferences 

Please note: unsubscribing will remove you from the Cochrane Fertility Regulation Group's mailing list, but it will not automatically unsubscribe you from other Cochrane Groups' mailing lists or from Cochrane’s organizational mailing lists which you can manage at account.cochrane.org.

Email Marketing Powered by Mailchimp